BDNF and Alzheimer disease: In women, APOE-4 was associated with increased Aβ deposition [54] and greater AD risk, although data on APOE–gender interaction are still controversial [55]; as previously described [45], no effects of APOE-4 on BDNF or interactions with gender were detected in the present study.